Lynch Syndrome clinical trials

Explore recruiting lynch syndrome clinical trials.

Recruiting lynch syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lynch Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

First in human pilot study to assess the safety and efficacy of dendritic cells loaded with frameshift derived neopeptides for the prevention of cancer in Lynch Syndrome carriers

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

AAS-Lynch - Assessment of the effect of a daily chemoprevention by aspirin low-dose of new or recurrent colorectal adenomas in patients with Lynch syndrome

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mesalamine for colorectal cancer prevention program in Lynch syndrome

Sweden, Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

IMHOTEP : Immunotherapy in MSI/dMMR Tumors in perioperative setting

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Watch-and-wait strategy to initiate Dostarlimab-based Immunotherapy in localized deficient mismatch repair (dMMR) and/or microsatellite instability high (MSI-H) oEso-gastric junction and gastric adenocarcinoma: A two cohort open-label GERCOR phase II study

France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Lynch Syndrome trials by city

Lynch Syndrome in Toronto Lynch Syndrome in Vancouver Lynch Syndrome in Montreal Lynch Syndrome in Calgary Lynch Syndrome in Edmonton Lynch Syndrome in Ottawa Lynch Syndrome in Winnipeg Lynch Syndrome in Quebec City Lynch Syndrome in Hamilton Lynch Syndrome in Kitchener Lynch Syndrome in London Lynch Syndrome in Halifax Lynch Syndrome in New York Lynch Syndrome in Los Angeles Lynch Syndrome in Chicago Lynch Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease